Researchers have proven that antibiotic-resistant strains of a harmful bacteria thrive in a diabetic infection environment.

Sotagliflozin, a drug recently approved by the Food and Drug Administration to treat type 2 diabetes and kidney disease with additional cardiovascular risk factors, can significantly reduce heart ...

The dual SGLT1/2 inhibitor sotagliflozin (Inpefa) reduced the risk for myocardial infarction (MI) and stroke in high-risk ...

Related: These Anti-Inflammatory Foods May Reduce COVID-19 Risk and Severity, According to New Study For those who haven’t ...

From menopause to stress, here is everything Black women need to know about living with and preventing heart disease.

Cardiovascular diseases claim more lives in the U.S. than all forms of cancer and accidental deaths combined, according to ...

After weeks of disruption to scientific federal grants, the National Institutes of Health has fallen behind in funding ...

Inflammation may be a health buzzword, but an anti-inflammatory diet is more than a trend—it can help you live a healthy life and age well. Inflammation gone wild can wreak havoc on the body and lead ...

A federal judge has temporarily blocked the NIH from making big cuts in medical research funding ordered by the Trump administration.

American Indian and Alaska Native communities are some of the most underserved minoritized groups in the United States, and ...

A popular diabetes drug just got a major new approval — and it could be a game-changer for millions of Americans at risk for kidney failure.

Depression hits the whole body, speeding the onset of long-term physical ills as people age, new research contends.